| Cutaneous melanoma P Rutkowski, PJ Wysocki, A Nasierowska-Guttmejer, A Jeziorski, ... Oncology in clinical practice 16 (4), 163-182, 2020 | 42 | 2020 |
| Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study P Rutkowski, A Indini, M De Luca, B Merelli, A Mariuk-Jarema, P Teterycz, ... Journal for immunotherapy of cancer 8 (2), 2020 | 38 | 2020 |
| Cutaneous melanomas P Rutkowski, PJ Wysocki Forum Dermatologicum 4 (1), 17-35, 2018 | 28 | 2018 |
| Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study F Dimitriou, K Namikawa, ILM Reijers, EI Buchbinder, JA Soon, ... Annals of Oncology 33 (9), 968-980, 2022 | 27 | 2022 |
| Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors G Kamińska-Winciorek, B Cybulska-Stopa, I Ługowska, M Ziobro, ... Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii …, 2019 | 26 | 2019 |
| BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma B Cybulska-Stopa, P Rogala, AM Czarnecka, L Galus, R Dziura, ... Melanoma Research 30 (5), 465-471, 2020 | 25 | 2020 |
| Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study B Cybulska-Stopa, I Ługowska, P Jagodzńska-Mucha, ... Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii …, 2019 | 22 | 2019 |
| Multimodal treatment of advanced mucosal melanoma in the era of modern immunotherapy P Teterycz, AM Czarnecka, A Indini, MJ Spałek, A Labianca, P Rogala, ... Cancers 12 (11), 3131, 2020 | 21 | 2020 |
| Efficacy of ipilimumab after anti-PD-1 therapy in sequential treatment of metastatic melanoma patients-Real world evidence B Cybulska-Stopa, P Rogala, AM Czarnecka, I Ługowska, P Teterycz, ... Advances in Medical Sciences 65 (2), 316-323, 2020 | 17 | 2020 |
| The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice P Rutkowski, M Ziętek, B Cybulska-Stopa, J Streb, S Głuszek, ... European Journal of Surgical Oncology 47 (5), 1191-1195, 2021 | 15 | 2021 |
| Expert recommendations on diagnostic-therapeutic management of melanoma patients P Rutkowski, PJ Wysocki, K Kozak, A Nasierowska-Guttmejer, A Jeziorski, ... Oncology in Clinical Practice 18 (6), 357-392, 2022 | 13 | 2022 |
| Evaluation of vinorelbine-based chemotherapy as the second or further-line treatment in patients with metastatic breast cancer B Cybulska-Stopa, M Ziobro, M Skoczek, E Kojs-Pasińska, I Cedrych, ... Contemporary Oncology/Współczesna Onkologia 17 (1), 78-82, 2013 | 13 | 2013 |
| Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV B Cybulska-Stopa, M Skoczek, M Ziobro, T Świtaj, S Falkowski, ... Contemporary Oncology/Współczesna Onkologia 16 (6), 532-545, 2012 | 13 | 2012 |
| Postępowanie diagnostyczno-terapeutyczne u chorych na mięsaki tkanek miękkich u dorosłych—zalecenia ekspertów P Rutkowski, H Koseła-Paterczyk, K Kozak, I Ługowska, J Fijuth, ... Onkol Prakt Klin Edu, 2022 | 12* | 2022 |
| Radiotherapy in the management of pediatric and adult osteosarcomas: a multi-institutional cohort analysis MJ Spałek, J Poleszczuk, AM Czarnecka, M Dudzisz-Śledź, ... Cells 10 (2), 366, 2021 | 12 | 2021 |
| Real-world treatment practice in patients with advanced melanoma B Cybulska-Stopa, K Piejko, R Pacholczak, M Domagała-Haduch, ... Contemporary Oncology/Współczesna Onkologia 24 (2), 118-124, 2020 | 12 | 2020 |
| High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors P Teterycz, P Jagodzinska-Mucha, B Cybulska-Stopa, A Mariuk-Jarema, ... Melanoma research 28 (5), 435-441, 2018 | 11 | 2018 |
| First-line treatment of advanced/metastatic melanoma with anti-PD-1 antibodies: multicenter experience in Poland B Cybulska-Stopa, R Pacholczak-Madej, G Kamińska-Winciorek, M Ziętek, ... Immunotherapy 13 (4), 297-307, 2021 | 10 | 2021 |
| Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma–real world multicenter cohort study M Słowińska, M Dudzisz‐Śledź, P Sobczuk, I Łasińska, A Pietruszka, ... Journal of the European Academy of Dermatology and Venereology 36 (8), 1219-1228, 2022 | 9 | 2022 |
| A practical approach to the 2022 ESC cardio-oncology guidelines: Comments by a team of experts–cardiologists and oncologists P Leszek, A Klotzka, S Bartuś, P Burchardt, AM Czarnecka, ... Polish Heart Journal (Kardiologia Polska) 81 (10), 1047-1063, 2023 | 8 | 2023 |
